Orexins and GLP-1s as they relate to long COVID and ME/CFS
A recent review highlighted the devastating multi-system effects of COVID on the body, particularly emphasising the endocrinological (hormonal) consequences manifesting…
Molecular understanding of ME/CFS: Genetics
Genetics (the study of segments of DNA called genes) and epigenetics (how environmental and other factors impact gene activity) are becoming…
No plans to develop a separate NHS specification for severe and very severe ME/CFS
When the ME/CFS Delivery Plan was published in July 2025 the Provision of Health Services section stated that the “DHSC,…
Markers in cerebrospinal fluid linked with ME/CFS disease heterogeneity
In 2023, Dr Bo Bertilson, a researcher and clinician at the Department of Neurobiology, Care Sciences and Society, Karolinska Institutet,…
Fundraising Focus – June 2026
Each month, Fundraising Focus is our way of saying thank you and celebrate the people behind the fundraising.
Movement for Good 2026 Winner – ME Research UK
ME Research UK is one of 10 winners in Benefact Group’s May 2026 Health and Wellbeing prize draw. The prize…
ME Research UK – e-newsletter May 2026
ME Awareness Week – A Recap Living with ME/CFS can be incredibly isolating, often due to major shifts in life…
Predatory journals – what are they, and what could they mean for ME/CFS research?
Predatory publishing, also known as deceptive or write-only publishing, occurs where journals charge authors publication fees without providing the legitimate…
Researcher Circle – April 2026
On the 23rd of April 2026, the fourth meeting of ME Research UK’s ‘Researcher Circle’ took place online. The Circle meets…
Pre-print – The case against deconditioning as the cause of ME/CFS
Last May, a team of researchers led by Braeden Charlton and including ME Research UK-funded researcher Associate Professor Rob Wüst…
